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Intestinal oxalate absorption is an important part of oxalate
metabolism influencing its urinary excretion and its
measurement can be a valuable diagnostic tool in
hyperoxaluric disorders. In this study, we use [13C2]oxalate
absorption under standardized dietary conditions to assess
intestinal oxalate absorption and its impact on urinary
oxalate excretion. Tests were conducted in age-matched
pediatric patients that included 60 with idiopathic calcium
oxalate urolithiasis, 13 with primary hyperoxaluria, and 35
healthy children. In the idiopathic stone formers, median
oxalate absorption was significantly higher than that in the
controls or in patients with primary disease. From
standardized values obtained in control patients, oxalate
hyperabsorption was detected in 23 patients with idiopathic
disease but not in any patients with primary hyperoxaluria;
therefore, a significant correlation between intestinal
absorption and urinary excretion was found only in those
with the idiopathic disease. We have shown that increased
intestinal oxalate absorption is an important risk factor of
idiopathic calcium oxalate urolithiasis. In contrast, low
intestinal oxalate absorption in patients with primary
hyperoxaluria indicates that only foods with excessive
oxalate content be restricted from their diet.
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Urinary oxalate excretion is believed to be a crucial factor for
the development of calcium oxalate (CaOx) stones, the most
common type of urinary calculi in children and adults.1–4
Physiologically, urinary oxalate originates in the majority
from its hepatic synthesis as an end product of metabolism
and in the minority from its intestinal absorption from
foodstuffs. Thus, hyperoxaluria may be a consequence of
endogenous overproduction of oxalate (primary hyper-
oxalurias (PHs)) or from its intestinal hyperabsorption
(secondary hyperoxalurias). The former situation is extre-
mely rare, whereas the latter is diagnosed in 3 to 420% of
children with urolithiasis and nephrocalcinosis.1,4,5 Besides
well-documented hyperabsorptive conditions, that is, post-
large intestinal resection, major bypass operations, or
inflammatory bowel diseases, most cases of secondary
hyperoxaluria are idiopathic.6,7 The studies on intestinal
oxalate absorption in idiopathic CaOx stone formers
performed in the past gave conflicting results. Some
showed higher absorption rates in urolithiasis patients in
comparison to healthy controls,8,9 whereas others did not.10
These discrepancies could be explained by small numbers
of patients and healthy volunteers based on the potential
radiation hazard, as 14C was used to label oxalate. Obviously,
for this reason, such studies were performed only in
adults.
The newly developed [13C2]oxalate absorption test is a
non-invasive (radioactivity-free) and relatively simple diag-
nostic tool that allows more intensive studies.11 Applying this
test, it was recently clearly shown that intestinal oxalate
hyperabsorption is an important risk factor for idiopathic
CaOx urolithiasis in adult patients.12,13 In children, however,
relevant data are not available. Therefore, we aimed to assess
intestinal absorption values of oxalate and its impact on
urinary oxalate excretion applying the [13C2]oxalate absorp-
tion test both in a healthy subgroup and in children and
adolescents with recurrent CaOx urolithiasis.
Although the contribution of intestinal oxalate absorption
to its urinary excretion in the PHs is theoretically low, no
relevant study confirmed this thesis. Thus, it is still a matter
of debate on whether a very restrictive low-oxalate diet has to
be recommended. We therefore also examined the intestinal
oxalate absorption in our pediatric patients with PH.
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RESULTS
Under the standardized conditions of the absorption test,
there was no statistically significant difference in urinary
oxalate excretion between children with CaOx urolithiasis
and healthy controls (0.495±0.170 vs 0.475±0.144 mmol
per 1.73 m2 per 24 h). Obviously, mean urinary oxalate
excretion was highest in PH patients (2.886±1.997 mmol per
1.73 m2 per 24 h; Table 1). The median intestinal oxalate
absorption of 15.3% in children with urolithiasis was
significantly higher than that in controls (10.4%) and in
PH patients (7%) (Po0.05 and Po0.001, respectively,
Figure 1). The absorption values in the latter group were
also significantly lower in comparison to the control group
(Po0.05). When analyzing boys and girls with CaOx
urolithiasis separately, both groups clearly had higher median
intestinal oxalate absorption than the controls: 17 vs 10.6%
for boys and 14.1 vs 9.6% for girls, respectively. However,
only in boys, the difference was statistically significant
(Po0.05). The results of the intestinal oxalate absorption
in all groups are shown in Table 2. The receiver operator
characteristic (ROC) analysis revealed that intestinal oxalate
absorption had an area under the curve of 0.656 for diagnosis
of children with CaOx urolithiasis. This result expresses a
reasonable accuracy but a less reasonable sensitivity and
specificity in setting a diagnostic cutoff value for oxalate
absorption. In other words, every possible cutoff does not
ideally discriminate the diseased children from the disease-
free children. The ROC analysis for the intestinal oxalate
absorption with several cutoff points is shown in Figure 2.
Therefore and as a compromise, we decided to assume
intestinal oxalate absorption above the 90th percentile
(18.6%) as abnormal. Above this value, the true-positive
rate amounts to 0.383 and the false-positive rate to 0.114.
Accordingly, increased intestinal oxalate absorption was
detected in 23 (38.3%) patients with CaOx urolithiasis and
in none of the patients with PH. A statistically significant
correlation between intestinal oxalate absorption and urinary
Table 1 | Urinary oxalate excretion (mmol per 1.73 m2 per
24 h) in pediatric patients with CaOx urolithiasis, PH, and in
healthy controls under standardized dietary conditions on
the second day of the oxalate absorption test
N Boys Girls Total
Patients with
CaOx urolithiasis
60 0.535±0.176 0.448±0.153 0.495±0.170
Patients with PH 13 2.156±0.739 4.054±2.869 2.886±1.997
Controls 35 0.483±0.153 0.459±0.131 0.475± 0.144
CaOx, calcium oxalate; PH, primary hyperoxaluria.
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Figure 1 | Comparison between pediatric patients with calcium
oxalate urolithiasis (CaOxU) and primary hyperoxaluria (PH) and
healthy controls in reference to intestinal oxalate absorption.
*significance of P-value CaOxU vs controls; Po0.05.
Table 2 | Intestinal oxalate absorption (%) in pediatric patients with CaOx urolithiasis, PH and in healthy controls
Patients with CaOx urolithiasis Patients with PH Controls
Boys (n=33) Girls (n=27) Total (n=60) Boys (n=8) Girls (n=5) Total (n=13) Boys (n=23) Girls (n=12) Total (n=35)
Median 17.0a 14.1 15.3b,c 8.2 7.1 7.0d 10.6 9.6 10.4
Range 2.6–32.8 1.7–37.7 1.7–37.7 2.0–12.4 1.8–10.0 1.8–12.4 4.3–26.2 1.9–18.6 1.9–26.2
CaOx, calcium oxalate; PH, primary hyperoxaluria.
aPo0.05 boys with CaOxU vs male controls.
bPo0.05 patients with CaOxU (total) vs controls (total).
cPo0.001 patients with CaOxU (total) vs PH patients (total).
dPo0.05 patients with PH (total) vs controls (total).
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Figure 2 | ROC curve for intestinal oxalate absorption (%)
determined from the results obtained in pediatric patients with
CaOx urolithiasis and healthy controls. Area under the curve:
0.656.
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oxalate excretion was found in the group of patients with
CaOx urolithiasis (r¼ 0.572, Po0.05; Figure 3). Both
parameters did not significantly correlate in the control
group (r¼ 0.282).
DISCUSSION
An etiological evaluation of children with urolithiasis poses a
particular challenge. In contrast to adults, an early onset of
the disease is more often associated with different underlying
metabolic conditions. To prevent recurrences of stone
episodes and to avoid severe complications, the underlying
cause of stone disease in childhood should be detected as
soon as possible and hence treated adequately. At present,
CaOx-containing stones are the most frequent type of
urolithiasis in children at least in western countries. A
routine metabolic evaluation of such cases includes the
urinary excretion of promoters (calcium, oxalate, uric acid)
and inhibitors (citrate, magnesium) of crystallization.
Although idiopathic hypercalciuria is supposedly diagnosed
more often than hyperoxaluria,1 the latter may play a more
crucial role in the pathogenesis of CaOx urolithiasis.14,15 This
thesis is based on the fact that in normal urine more than 10
calcium ions are available for each oxalate ion and both
ingredients crystallize in a relationship of 1:1. Therefore, even
small increases in urinary oxalate excretion accelerate CaOx
crystalline mass production.16
It is well known that elevation of urinary oxalate excretion
in most cases of secondary hyperoxaluria is ‘mild’
(0.5–1.0 mmol per 1.73 m2 per 24 h), that is, does not reach
a level found in the PHs (41.0 mmol per 1.73 m2 per 24 h). It
is caused by higher intestinal absorption of oxalic acid
because of either an excessive dietary intake or enteric
hyperabsorption per se.2,17 Evaluation of dietary oxalate
intake is rather simple, whereas assessment of an effect of
intestinal oxalate absorption on its urinary excretion causes
methodological problems. In the past, several methods were
used for this purpose but due to their inconveniencies, that
is, the excessive sodium oxalate load or the ingestion of
radioactive [14C]oxalate, they did not find way to common
clinical practice.8–10,18 The introduction of the safe and
simple [13C2]oxalate test now allowed studies comprising
larger groups of adult patients with stone disease as well as
healthy subjects.11–13,19–22 One of these studies showed that
the median intestinal oxalate absorption was significantly
higher in patients with CaOx urolithiasis when compared
with healthy volunteers (9.45 vs 6.85%).13 This is in
agreement with the results of our study, but the median
intestinal oxalate absorption in children and adolescents was
considerably higher than that in adults with 15.3% for
patients vs 10.5% for healthy controls. Similar to adult data,
when analyzing boys and girls separately, both groups had
significantly higher absorption rates than controls.13 Inter-
estingly, the boys with urolithiasis showed the highest median
intestinal oxalate absorption (17%). A tendency to higher
intestinal oxalate absorption in male patients was also found
in adults.12,13 It is well known that males of all age groups
with or without urolithiasis excrete significantly higher
amounts of oxalate in urine than females.23–25 Therefore,
the higher intestinal oxalate absorption in males may partly
explain this observation.
Although the pathogenesis of PH is originally associated
with endogenous overproduction of oxalic acid, there is
dispute about the necessity of a specifically low-oxalate diet
in this condition.26 From a theoretical point of view, such
recommendation could keep the contribution of the
exogenous oxalate source to the total urinary oxalate amount
at the lowest possible level. However, our results showed that
the median intestinal oxalate absorption in this group of
patients is low (7%) and even significantly lower than that in
healthy controls. We speculate that the lower absorption
could be caused by a downregulation of absorption or a
change of shift of intestinal oxalate transporters such as
SLC26A6 in case of an extremely high body oxalate burden.27
Hence, oxalate would much more be intestinally secreted,
than absorbed.
The reference values of intestinal oxalate absorption in
healthy adults are still a matter of debate. The studies
performed with [14C]oxalate defined the upper normal limit
of oxalate absorption at 10%. However, owing to small
number (maximum 20) of volunteers, this value may be
questionable.8,9 Recently, the results of the [13C2]oxalate
absorption test performed in 120 healthy subjects showed
that the interindividual and intraindividual variance of
intestinal oxalate absorption was high (3.39±1.68%) and
the reference range in 95% of the individuals was 2.2–18.5%.
Therefore, the authors suggested that values higher than 15%
are an indicator for increased intestinal oxalate absorption.20
The ROC curve for intestinal oxalate absorption in our study
showed that every possible cutoff does not ideally discrimi-
nate the diseased children from the disease-free children. This
situation was caused by the significant overlap of oxalate
absorption values in both groups, which is reflected in a
relatively small area under the ROC curve (0.656). For
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Figure 3 | Correlation between intestinal oxalate absorption and
oxalate excretion in 24-h urines in pediatric patients with CaOx
urolithiasis. *significance of Po0.05 for correlation between
intestinal oxalate absorption and urinary oxalate excretion.
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comparison, an area of 1 represents a perfectly discriminating
diagnostic test and an area under 0.5 expresses a worthless
test. The results of the ROC analysis in our study are not
surprising because the pathogenesis of CaOx stone disease is
obviously multifactorial. Therefore, the increased intestinal
oxalate absorption seems to be a contributing factor only in a
part of children with urolithiasis. It is also possible that
a larger group of healthy subjects could improve the results of
the ROC analysis. Unfortunately, we were only able to
perform the [13C2]oxalate absorption test in 35 healthy
children. Performing a 2-day test under dietary restrictions
and other limitations in healthy children is extremely difficult
and prone to compliance problems. Therefore and as
a significant increase of numbers was not anticipated, as a
compromise, we decided to assume values of oxalate
intestinal absorption above 90th percentile (18.6%) in our
controls as abnormal. For this cutoff point, the true-positive
rate amounts to 0.383 and false-positive rate to 0.114.
Accordingly, 38.3% of children with CaOx urolithiasis
showed increased intestinal oxalate absorption. This con-
firmed our observation that intestinal oxalate absorption in
children may be physiologically higher than that of adults. In
adult stone formers who underwent the same test, the
percentage of hyperabsorbers was clearly lower with
B20%.13 In the contrary, none of the PH patients showed
an increase in oxalate absorption.
Only in children with urolithiasis, we found a significant
correlation between the daily urinary oxalate excretion and
the intestinal oxalate absorption. The same relationship was
found in adult patients with urolithiasis and in much lesser
degree in healthy adult volunteers.12,13 However, it should be
emphasized that during the standardized conditions of the
test, the exogenous oxalate load is low, which has even less
influence on urinary oxalate excretion in hyperabsorptive
conditions. Therefore, the correlation between oxalate
absorption and urinary oxalate excretion in patients was
not more pronounced (r¼ 0.572) and was absent in healthy
children. This could also explain the only slightly higher 24-h
urinary oxalate excretion during the test in the group of
patients compared to that in the controls. In other words,
under normal conditions, in individuals with a high risk of
hyperabsorption, an even small increase in oxalate intake
could result in dramatic consequences.
We can only speculate about possible mechanisms of
intestinal oxalate hyperabsorption in our large group of
pediatric CaOx stone formers. First, the process of oxalate
absorption might be genetically determined and might
therefore be characteristic for each individual.28 Presently,
mutations in the SLC26 gene family are studied as a potential
cause of a disturbed oxalate transport in the small intestine.29
The second possibility might be an influence of intestinal
oxalate-degrading organisms, particularly Oxalobacter
formigenes, on the intestinal oxalate absorption. It was found
that 65–80% of healthy adults and up to 90% of children aged
3–10 years are colonized with Oxalobacter.30,31 Hence, several
studies showed a correlation between hyperoxaluria and the
absence of intestinal colonization with O. formigenes.32–34
Unfortunately, we were not able to assess the coloniza-
tion rate with O. formigenes in all our studied patients,
but the patients with PH tested were all negative for
Oxalobacter.
The identification of oxalate hyperabsorbers among
patients with CaOx urolithiasis has several implications
regarding their management. In this group of patients,
evaluation of dietary habits to avoid foods rich in oxalate and
to assess the calcium and magnesium content of food items is
clearly helpful. It was shown that adequate calcium and
magnesium intake may decrease intestinal oxalate absorption
effectively.21 Our results confirmed the opinion that patients
with PH would not benefit from extremely low-oxalate diets.
However, they should avoid food with very high oxalate
contents (for example, spinach, rhubarb, beet root, and
ice tea).
In addition, the treatment with O. formigenes in case of its
absence in patients with secondary hyperoxaluria as well as
PH could be a potential new therapeutic tool.35
CONCLUSION
Intestinal hyperabsorption of oxalate is an important
lithogenic risk factor in children with CaOx urolithiasis. It
was found in one-third of our patients with stone disease. Its
mechanism is not yet clear but may either be due to
mutations of intestinal oxalate transporter genes or due to a
lack of intestinal oxalate-degrading bacteria. Oxalate absorp-
tion in children is clearly higher than that in adults, both in
stone patients and in healthy subjects. However, a larger
cohort of healthy children and adolescents would have to be
tested to establish more reliable reference values. At present,
we regard values above 18.6% as intestinal oxalate hyper-
absorption in children. In contrast, patients with PH show
very low intestinal oxalate absorption rates. The identifica-
tion of patients with high oxalate absorption allows the
introduction of a causative therapy (for example, low-oxalate
diet) to prevent stone recurrences.
MATERIALS AND METHODS
The study comprised 60 children and adolescents (33 boys and 27
girls) aged 4.3–18 years (mean: 13.3±4.1 years) with recurrent
idiopathic urolithiasis and 13 patients (8 boys and 5 girls) aged
3.5–16.4 years (mean: 10.2±3.9 years) with PH. Stone analysis was
performed by infrared spectroscopy in 36 (60%) of children with
CaOx urolithiasis and showed CaOx (whewellite, weddellite, pure or
mixed) in all cases. In the remaining children, an assessment of
stone composition was impossible due to their stone loss after
lithotripsy (extracorporeal shock wave lithotripsy) or an unnoticed
spontaneous passage. However, CaOx urolithiasis was suspected
because all calculi were radiopaque, other possible types of stones
(infection-related or cystine stones) were clinically and metabolically
excluded, and more than 75% of kidney stones overall are composed
of CaOx. During the study, all patients had no urinary tract
infection and did not receive antibiotic treatment, but remained on
their normal medication such as alkaline citrate or pyridoxine in
patients with PH. No patient had received antibiotic treatment for
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more than 3 months before the study. The patients had no history of
inflammatory bowel diseases, nor did they have bowel surgery. All
patients with idiopathic CaOx urolithiasis had normal renal
function expressed as normal serum creatinine or cystatin C levels,
or calculated glomerular filtration rate according to Schwartz.36 The
renal function in patients with PH was normal (480 ml min1) in
11, but decreased in 2 patients (450 to o80 ml min1).
A group of 35 healthy children (23 boys and 12 girls) aged
5.7–16.8 years (mean 11.1±3.6 years) without a history of
urolithiasis or nephrocalcinosis, with normal kidney function, no
bowel diseases, and without antibiotic treatment for the last months
served as controls.
The [13C2]oxalate absorption test was performed according to its
description for adults but with minor modifications for younger
children.11 The test was carried out over a period of 2 consecutive
days under standardized dietary conditions: 2400 ml per 1.73 m2
body surface area of fluid was distributed evenly over the day. The
diet supplied approximately 40 kcal per kg body weight per day, and
the calcium and oxalate intake was 800 and 57 mg day1,
respectively. The first test day was designed to achieve a steady
state (stable concentration of urinary solutes) for the purpose of an
adequate calibration procedure. The next day was the main test
period when a capsule with either 25 mg (body weight p30 kg) or
50 mg (body weight 430 kg) of the disodium salt of [13C2]oxalate
(Promochem, Wesel, Germany) was orally administered. On both
study days, a 24-h urine was collected into five storage bottles
containing 25% HCl as the preservative. The timed scheme of urine
collection during the test is given in Table 3. After the test, aliquots
of 0.1 ml urine from every study period were taken and stored at
20 1C. The absorption measurement was subsequently performed
as previously described in detail.11 In brief, organic acids were
extracted from the aliquots and derivatized with N-methyl-tert.
-butyldimethylsilyltrifluoroacetamide. Samples were then measured
by gas chromatography/mass spectrometry. The selected ion modes
at m/z 261.3, 263.3, and 274.3 were used to quantify the unlabeled
oxalic acid, labeled oxalic acid, and the internal standard
[213C]malonic acid, respectively. Oxalate absorption was calculated
from the amount of [13C2]oxalate in the 24-h urine and expressed as
percentage of the dose of [13C2]oxalate ingested via the capsule.
The statistical analysis was performed by the software Statistica
(StatSoft Inc., Tulsa, OK, USA) for Windows, version 7.1. The
specific differences between healthy controls and patients were
calculated by the non-parametric Mann–Whitney U-test for two
groups and by the Kruskal–Wallis non-parametric analysis of
variance for three groups. The correlations were tested with the
Spearman test. Additionally, ROC analysis was used to evaluate
the accuracy of the [13C2]oxalate absorption test in separating the
tested groups.37 A P-value less than 0.05 was considered statistically
significant.
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